Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/05/2012CA2520000C Compositions and methods for treating cancer
06/05/2012CA2519787C Methods of treating diabetes by blocking vegf-mediated activity
06/05/2012CA2519278C Esterified fatty acid composition
06/05/2012CA2508024C Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
06/05/2012CA2507530C Rapamycin and il-10 for the treatment of immune diseases
06/05/2012CA2489041C Bafilomycin-like metabolite from a novel micromonospora species
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
06/05/2012CA2475766C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/05/2012CA2446439C .delta.4-desaturase genes and uses thereof
06/05/2012CA2435419C Halogenated composition, method for preparing same and uses thereof
06/05/2012CA2431207C Compositions containing inclusion complexes
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2397359C Composition of antigen and glycolipid adjuvant sublingual administration
06/05/2012CA2324226C Inhibitors of caspases
06/05/2012CA2286575C Sustained-release compositions and method for preparing same
06/05/2012CA2249352C Immunoliposomes that optimize internalization into target cells
06/05/2012CA2248667C Hla-a2.1 binding peptides and their uses
06/05/2012CA2233534C Manipulation of non-terminally differentiated cells using the notch pathway
05/2012
05/31/2012WO2012071573A2 Materials and methods for the prevention and treatment of cancer
05/31/2012WO2012071562A2 Methods of screening compounds that are cytotoxic to tumor cells and methods of treating tumor cells using such compound
05/31/2012WO2012071519A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012WO2012071517A2 Novel crystalline forms
05/31/2012WO2012071511A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
05/31/2012WO2012071509A2 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012WO2012071501A1 Benzoxazepines asn inhibitors of p13k/m tor and methods of their use and manufacture
05/31/2012WO2012071492A1 Mir-200 family induces mesenchymal-to-epithelial transition (met) in ovarian cancer cells
05/31/2012WO2012071480A2 Lipophilic glucocorticosteroid monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
05/31/2012WO2012071469A2 Histone demethylase inhibitors and uses thereof for treatment o f cancer
05/31/2012WO2012071459A1 New indication for use of niacin (nicotinic acid) for treatment, prevention and reversal of fatty liver disease
05/31/2012WO2012071458A1 Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases
05/31/2012WO2012071425A1 Solid state forms of sorafenib besylate, and processes for preparations thereof
05/31/2012WO2012071414A2 Quinoxaline compounds and uses thereof
05/31/2012WO2012071383A2 Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapy
05/31/2012WO2012071374A1 Methods of treatment using selective bcl-2 inhibitors
05/31/2012WO2012071369A2 A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
05/31/2012WO2012071336A1 Salts and crystalline forms of an apoptosis-inducing agent
05/31/2012WO2012071324A2 Pharmaceutical compositions
05/31/2012WO2012071321A1 Method of treating cancer
05/31/2012WO2012071310A1 Integrin-linked kinase inhibitors
05/31/2012WO2012071295A1 Therapeutic treatment for metabolic syndrome, type 2 diabetes, obestiy or prediabetes
05/31/2012WO2012071279A1 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
05/31/2012WO2012071238A2 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
05/31/2012WO2012071221A2 Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron
05/31/2012WO2012071212A2 Novel phosphonic acids as s1p receptor modulators
05/31/2012WO2012071186A1 Modulators of s1p receptors
05/31/2012WO2012071184A1 Indole derivatives as modulators of s1p receptors
05/31/2012WO2012071152A2 Method of treating neurological conditions with extract of nerium species or thevetia species
05/31/2012WO2012071096A2 Arid1a and ppp2r1a mutations in cancer
05/31/2012WO2012071027A2 Nutraceutical based topical anxiolytic agent and method of use
05/31/2012WO2012070973A1 Method for treating cancer patients
05/31/2012WO2012070972A1 Method for treating cardiovascular disease patients
05/31/2012WO2012070967A1 Wound-healing, burn-treating, regenerative and antiviral pharmaceutical composition for topical application
05/31/2012WO2012070965A1 Modified anticomplementary oligonucleotides with anticancer properties and method for producing same
05/31/2012WO2012070920A1 Formulation for controlling and eliminating seborrhea and alopecia on the scalp
05/31/2012WO2012070890A2 Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
05/31/2012WO2012070798A2 Topical antifungal composition comprising terbinafine or its salt
05/31/2012WO2012070785A1 Sustained-release pharmaceutical composition comprising levetiracetam or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
05/31/2012WO2012070702A1 Composition containing orlistat and chitosan and preparation method thereof
05/31/2012WO2012070701A1 Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same
05/31/2012WO2012070700A1 Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same
05/31/2012WO2012070656A1 Process for production of hydroxystilbene derivative having physiological activity
05/31/2012WO2012070649A1 Highly-soluble pyrroloquinoline quinone salt and method for producing same
05/31/2012WO2012070621A1 Use of age-specific aptamer for treating renal disease
05/31/2012WO2012070601A1 Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012070071A1 Compounds and their use
05/31/2012WO2012070066A1 Process for the preparation of taurolidine and its intermediates thereof
05/31/2012WO2012070062A2 Novel polymorph of nilotinib hydrochloride
05/31/2012WO2012070059A1 Fingolimod polymorphs and their processes
05/31/2012WO2012070051A1 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
05/31/2012WO2012070043A1 Method and composition for weight-gain management
05/31/2012WO2012070040A1 Compositions and methods for ameliorating renal dysfunction induced by renal hypoperfusion or acute kidney injury
05/31/2012WO2012070034A1 A drug delivery device
05/31/2012WO2012070030A1 A pharmaceutical composition
05/31/2012WO2012070027A1 A drug delivery device
05/31/2012WO2012070024A1 Carbonic anhydrase inhibitors with antimetastatic activity
05/31/2012WO2012069972A1 A pharmaceutical combination for the treatment of breast cancer
05/31/2012WO2012069948A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069856A1 Antimalarial compounds
05/31/2012WO2012069852A1 Pharmaceutical compounds as inhibitors of sphingosine kinase
05/31/2012WO2012069842A1 Combination of a cyslt1 antagonist with an anti -arthritic drug for the treatment of arthritic disorder
05/31/2012WO2012069790A1 Therapeutic use of compounds
05/31/2012WO2012069743A1 Nitrobenzothiazole derivatives and use thereof for treating tuberculosis
05/31/2012WO2012069679A1 Marine, calcium channel antagonist compounds for treating cardiovascular diseases
05/31/2012WO2012069658A2 Immunomodulatory compositions
05/31/2012WO2012069620A1 Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
05/31/2012WO2012069608A1 Technetium-99m complex as a tool for the in vivo diagnosis of cancerous tumours
05/31/2012WO2012069605A1 Novel e,e-diene compounds and their use as medicaments and cosmetics
05/31/2012WO2012069601A1 Substituted quinazolines as fungicides
05/31/2012WO2012069591A1 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
05/31/2012WO2012069525A1 Inhibitors of sp140 and their use in therapy
05/31/2012WO2012069503A1 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
05/31/2012WO2012069442A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
05/31/2012WO2012069432A1 Use of kinesin inhibitors in hiv infection treatment and a method for screening them
05/31/2012WO2012069428A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
05/31/2012WO2012069427A1 Solid dosage forms of oleyl phosphocholine
05/31/2012WO2012069421A1 Calcium-sensing receptor-active compounds
05/31/2012WO2012069419A1 Calcium-sensing receptor-active compounds
05/31/2012WO2012069416A1 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
1 ... 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 ... 7860